dr. lenz on next steps with immunotherapy in mcrc
Published 5 years ago • 405 plays • Length 1:00Download video MP4
Download video MP3
Similar videos
-
1:37
dr. overman on next steps with immunotherapy in mcrc
-
0:53
dr. lenz on potential for immunotherapy in mcrc
-
1:14
dr. lenz on updated results of the checkmate-142 trial in mcrc
-
1:54
dr. lenz on updated data from checkmate 142 with nivolumab ipilimumab in mcrc
-
1:27
dr. lenz on later-line combo approaches in crc
-
1:19
dr. lenz on need for new treatment strategies in colorectal cancer
-
2:04
dr. lenz on the changing landscape of metastatic colorectal cancer
-
1:35
dr. lockhart on next steps for regorafenib and tas-102 in mcrc
-
2:13
dr. lenz on the benefit of regorafenib in crc
-
1:13
dr. lenz on breakthrough designation of encorafenib, binimetinib, and cetuximab in braf crc
-
1:12
dr. lenz on choosing between regorafenib and tas-102 in crc
-
1:07
dr. bendell on the next steps following progression on immunotherapy in msi-h crc
-
1:03
dr. lenz on the updated findings from the checkmate-142 trial in mcrc
-
0:53
dr. lenz on the safety profile of checkmate-142 trial in crc
-
2:24
dr. lenz on optimal sequencing strategies in crc
-
2:15
dr. lenz discusses frontline nivolumab plus ipilimumab in mcrc
-
1:58
dr. kasi on role of immunotherapy in mcrc
-
1:13
dr. morris on the design of the cobra trial in stage ii colon cancer
-
1:57
dr. benson on the ongoing research with immunotherapy in mcrc